Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks.

× No keyword cloud information.

18 in total

1. Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degeneration.

Authors: Quan Dong Nguyen; Syed Mahmood Shah; Gulnar Hafiz; Diana V Do; Julia A Haller; Roberto Pili; Ingrid E Zimmer-Galler; Kashif Janjua; R C Andrew Symons; Peter A Campochiaro
Journal: Am J Ophthalmol Date: 2007-12-11 Impact factor: 5.258

2. Intravitreal bevacizumab for choroidal neovascular membrane associated with Best's vitelliform dystrophy.

Authors: Ekta Rishi; Pukhraj Rishi; Sheshadri Mahajan
Journal: Indian J Ophthalmol Date: 2010 Mar-Apr Impact factor: 1.848

3. Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks.

Authors: Alfredo Pece; Gaetano Russo; Federico Ricci; Vincenzo Isola; Ugo Introini; Giuseppe Querques
Journal: Clin Ophthalmol Date: 2010-06-24

4. Intravitreal bevacizumab: an analysis of the evidence.

Authors: Derrick P Smit; David Meyer
Journal: Clin Ophthalmol Date: 2007-09

5. Intravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis.

Authors: Salim Ben Yahia; Carl P Herbort; Salah Jenzeri; Kamel Hmidi; Sonia Attia; Riadh Messaoud; Moncef Khairallah
Journal: Int Ophthalmol Date: 2008-04-10 Impact factor: 2.031

6. Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin) for treatment of angoid streaks in pseudoxanthoma elasticum.

Authors: Martin Ganssauge; Helmut Wilhelm; Karl-Ulrich Bartz-Schmidt; Sabine Aisenbrey
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2009-12 Impact factor: 3.117

Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks.

1. Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degeneration.

2. Intravitreal bevacizumab for choroidal neovascular membrane associated with Best's vitelliform dystrophy.

3. Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks.

4. Intravitreal bevacizumab: an analysis of the evidence.

5. Intravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis.

6. Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin) for treatment of angoid streaks in pseudoxanthoma elasticum.

7. Intravitreal bevacizumab for choroidal neovascularization secondary to non-age-related macular degeneration.

8. Vascular endothelial growth factors and their inhibitors in ocular neovascular disorders.

9. Choroidal neovascularization after blunt ocular trauma in angioid streaks.

Review 10. Bevacizumab: off-label use in ophthalmology.